Daguluan, Hajija G.
HRN: 20-84-35 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/12/2025
CEFTRIAXONE 1G (VIAL)
05/12/2025
05/19/2025
IV
2gm
OD
Infected Wound Right Hand
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes